EUVIMEDEUVIMED entdecken
Kohortenstudie

The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study

Elisa Molinelli, Edoardo De Simoni iD, Maria Luisa Dragonetti, Sara Belleggia, Andrea Maurizi, Daisy Gambini, Annamaria Offidani, Oriana Simonetti

Clinical and Experimental Dermatology · 24.04.2025 · 50 (5) · 1002-1005

DOI: 10.1093/ced/llae540 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 26.12.2024. Verfasst von Elisa Molinelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Contraceptives, Oral, Combined, Estrogens, Progesterone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease characterized by recurrent painful nodules, abscesses and sinus tracts on the apocrine gland-bearing skin. The role of sex hormones in the pathogenesis as well as the use of hormonal treatment in the management of HS is still debated. We performed a retrospective cohort study, including 183 patients, to assess the influence of the combined oral contraceptive (oestrogen–progesterone COC) on HS onset and disease severity. Univariable and multivariable analyses highlighted that the patients undergoing COC therapy had a later onset of HS, more precisely 9.81 years after the patients who have not received COC, independently of body mass index, family history, smoking, acne, age of menarche and concomitant gynaecological disorders. This study suggests that COC use could influence the development and the progression of HS and supports the key role of sex hormones in the pathogenesis of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaContraceptives, Oral, CombinedEstrogensProgesteroneContraceptives, Oral, HormonalHumansRetrospective StudiesFemaleAdultMiddle AgedYoung AdultSeverity of Illness Index

Substanzen

Contraceptives, Oral, CombinedEstrogensProgesteroneContraceptives, Oral, Hormonal

Autor:innen und Institutionen

  • Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.

ORCID-Profile: Edoardo De Simoni

Zitieren

APA

Molinelli, E., De Simoni, E., Dragonetti, M. L., Belleggia, S., Maurizi, A., Gambini, D., Offidani, A., & Simonetti, O. (2025). The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study. Clinical and Experimental Dermatology, 50(5), 1002-1005. https://doi.org/10.1093/ced/llae540

Vancouver

Molinelli E, De Simoni E, Dragonetti ML, Belleggia S, Maurizi A, Gambini D, et al. The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study. Clinical and Experimental Dermatology. 2025;50(5):1002-1005. doi:10.1093/ced/llae540

BibTeX
@article{Molinelli2025,
  author = {Molinelli, Elisa and De Simoni, Edoardo and Dragonetti, Maria Luisa and Belleggia, Sara and Maurizi, Andrea and Gambini, Daisy and Offidani, Annamaria and Simonetti, Oriana},
  title = {The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  volume = {50},
  number = {5},
  pages = {1002--1005},
  doi = {10.1093/ced/llae540}
}
Kostenlos starten →